Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

身体检查 身体检查

Binu V John, Smitha Mary Thomas

    Lancet (London, England)
    |December 20, 2003
    PubMed
    概括

    No abstract available in PubMed .

    相关实验视频

    相关概念视频

    您也可能阅读

    相关文章

    通过共同作者、期刊和引用图与本文相关的文章。

    排序
    Same author

    Clinical Features and Outcomes of Lean Metabolic Dysfunction-Associated Steatotic Liver Disease With Increased Alcohol Intake.

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026
    Same author

    Alpha-1 Antitrypsin Deficiency in Patients With Cirrhosis in a US National Cohort.

    Clinical and translational gastroenterology·2026
    Same author

    Hepatocellular carcinoma risk in metabolic dysfunction-associated steatotic liver disease with increased alcohol intake (MetALD).

    JHEP reports : innovation in hepatology·2026
    Same author

    AGA Clinical Practice Update on the Management of Ascites, Volume Overload, and Hyponatremia in Cirrhosis: Expert Review.

    Gastroenterology·2025
    Same author

    Reply: Assessing HCC incidence and surveillance thresholds in non-cirrhotic MASLD.

    Hepatology (Baltimore, Md.)·2025
    Same author

    Reply: Are we overestimating LSM-based HCC risk in MASLD? Addressing immortal time bias.

    Hepatology (Baltimore, Md.)·2025
    Same journal

    Assisted dying and the silencing of medicine's next generation.

    Lancet (London, England)·2026
    Same journal

    Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

    Lancet (London, England)·2026
    Same journal

    Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

    Lancet (London, England)·2026
    Same journal

    [<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

    Lancet (London, England)·2026
    Same journal

    Research priorities for characterising Bundibugyo virus.

    Lancet (London, England)·2026
    Same journal

    Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

    Lancet (London, England)·2026
    查看所有相关文章